Kawasaki disease other diagnostic studies

Jump to: navigation, search

Kawasaki disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Kawasaki disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Kawasaki disease other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Kawasaki disease other diagnostic studies

CDC on Kawasaki disease other diagnostic studies

Kawasaki disease other diagnostic studies in the news

Blogs on Kawasaki disease other diagnostic studies

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Kawasaki disease other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]

Overview

Urinalysis, lumbar puncture, biomarkers evaluation, and angiography may be helpful in the diagnosis of Kawasaki disease.

Other Diagnostic Studies

Other diagnostic tests include:[1]

  • Urinalysis
    • May demonstrate white blood cells and protein in the urine (sterile pyuria and proteinuria, respectively) without any evidence of bacterial growth.
  • Lumbar puncture
  • Angiography
    • May be used to detect coronary artery aneurysms and remains the gold standard for their detection, but is rarely used today unless coronary artery aneurysms have already been detected by echocardiography.
  • Biomarkers
    • Soluble LR11 may provide evidence of vascular lesions in Kawasaki disease.

References

  1. Watanabe K, Suzuki H, Jiang M, Haniu H, Numano F, Hoshina S, Saitoh A, Uchiyama M, Bujo H (March 2016). "Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease". Atherosclerosis. 246: 94–7. doi:10.1016/j.atherosclerosis.2015.12.035. PMID 26761773.

Linked-in.jpg